Breast cancer is one of the most prevalent cancers in women; about one in eight women will be affected by it. Also, it is one of the leading causes of death in women. It is critical to get involved in breast screening to enable early detection with consequent decreased morbidity and mortality associated with breast cancer.
Screening mammography is estimated to reduce breast cancer mortality by almost 40% if performed on an annual basis rather than less frequently. Screening for breast cancer can also involve ultrasound and MRI depending on the age and individualized risk for a patient.
Imaging for breast cancer involves screening as well as diagnostic modalities. BI-RADS (breast imaging-reporting and data system) categories are used to categorize breast imaging reports. The diagnosis of breast cancer is established with the use of image-guided biopsies involving ultrasound, stereotactic guidance, and MRI. These also play a critical role in treatment planning and monitoring.
The following discussion will elaborate on the different imaging modalities used for the screening and diagnosis of breast cancer.
Breast cancer screening Risk factors for breast cancer Functional unit of the breast Ultrasound MRI BI-RADS TNM staging
This is a preview of subscription content, log in to check access.
Lee SC, Jain PA, Jethwa SC, Tripathy D, Yamashita MW. Radiologist’s role in breast cancer staging: providing key information for clinicians. Radiographics. 2014;34(2):330–42.CrossRefGoogle Scholar
Chen L, Chantra PK, Larsen LH, Barton P, Rohitopakarn M, Zhu EQ, et al. Imaging characteristics of malignant lesions of the male breast. Radiographics. 2006;26(4):993–1006.CrossRefGoogle Scholar
Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19(Suppl 1):14–25.CrossRefGoogle Scholar
Chen W. Patient education: factors that modify breast cancer risk in women (beyond the basics). https://www.uptodate.com.
Nicholson BT, Harvey JA, Cohen MA. Nipple-areolar complex: normal anatomy and benign and malignant processes. Radiographics. 2009;29(2):509–23.CrossRefGoogle Scholar
American College of Radiology. Benefits and limitations of mammography. Digest of Council Action 2015-2016: 2002, amended 2012 (Res. 23-c).Google Scholar
Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, et al. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. 2014;106(11)Google Scholar
Helquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, et al. Effectiveness of population-based service screening with mammography for women ages 40-49 years. Cancer. 2010;117(4):714–22.CrossRefGoogle Scholar
Helvie MA, Chang JT, Hendrick RE, Banerjee M. Reduction in late-stage breast cancer incidence in the mammography era. Cancer. 2014;120(17):2649–56.CrossRefGoogle Scholar
Koroukian SM, Bakaki PM, Htoo PT, Han X, Schluchter M, Owusu C, et al. The breast and cervical cancer early detection program, medicaid, and breast cancer outcomes among Ohio’s underserved women. Cancer. 2017;123(16):3097–106.CrossRefGoogle Scholar
Hendrick RE, Helvie MA. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death. AJR Am J Roentgenol. 2012;198:723–8.CrossRefGoogle Scholar
Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2014. https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Bethesda, MD: National Cancer Institute; 2017.
Grady D, Redberg R. Physician adherence to breast cancer screening recommendations. JAMA Intern Med. 2017;177(6):763–4.CrossRefGoogle Scholar